Priority Date: 30.01.03 (US 20030354090)

Survivin-derived peptides and use thereof

  • Application ID: EP14191677
  • Status: The patent has been granted


Employment test 51 - 200 employees
Company dna plougmann and vingtoft
operating since 1967
Headquarter in Copenhagen and 6 offices
active in Legal Services, IP Consulting, IP Portfolio Processing, and IP-related Communication Service


This EP application has the IPC combination A61, C07, and G01. Plougmann & Vingtoft A/S is specialized in the combination A61, C07, and G01. We found, that TransMIT GmbH, Kailuweit & Uhlemann, dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB, Avidity IP Ltd, Mewburn Ellis LLP and 55 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.


  • 30.01.2003 - Priority Date (US 20030354090)
  • 08.04.2015 - Publication A1 (EP2857035)
  • 29.11.2017 - Publication B1 (EP2857035)